AN UNBIASED VIEW OF LINK ALTERNATIF MBL77

Not all individuals with CLL have to have therapy. Even with all latest advancements, the iwCLL however endorses watchful observation for patients with asymptomatic disorder.86 This suggestion is based on a minimum of two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR